Atlas Trials

A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease

Clinical trial NCT04671771 · RECRUITING

Trial details

NCT number
NCT04671771
Sponsor
W.L.Gore & Associates
Status
RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
End Stage Renal Disease (ESRD)Kidney FailureChronic Renal DiseaseHemodialysis
Start date
2020-12-03
Primary completion
2027-12-01
Enrollment
133

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.